Assessing the Immunogenicity of pING-hHER3FL
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Cancer
Interventions: BIOLOGICAL: pING-hHER3FL
Sponsor: Herbert Lyerly